Tumor cell-platelet-endothelial cell interactions and prostaglandin metabolism
- PMID: 2960216
Tumor cell-platelet-endothelial cell interactions and prostaglandin metabolism
Abstract
We have proposed that tumor cell induction of platelet aggregation facilitates tumor cell attachment to endothelium and that this attachment is limited by endogenous PGI2. We have developed an in vitro model to study tumor cell-platelet-endothelial cell interactions in which endothelial cells are grown on microcarrier beads. Untreated endothelial cells inhibit tumor cell-induced platelet aggregation, as well as tumor cell attachment to endothelial cells. Inhibition of endothelial cell PGI2 production by indomethacin obviates this inhibition.
Similar articles
-
A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis.Cancer Res. 1987 May 1;47(9):2425-32. Cancer Res. 1987. PMID: 3552214
-
Inhibition of tumor cell induced platelet aggregation by prostacyclin and carbacyclin: an ultrastructural study.Invasion Metastasis. 1987;7(2):109-28. Invasion Metastasis. 1987. PMID: 3294727
-
In vitro studies of thromboresistance: the role of prostacyclin (PGI2) in platelet adhesion to cultured normal and virally transformed human vascular endothelial cells.Lab Invest. 1980 Mar;42(3):366-74. Lab Invest. 1980. PMID: 6244462
-
Metastatic cell attachment to and invasion of vascular endothelium and its underlying basal lamina using endothelial cell monolayers.Symp Fundam Cancer Res. 1983;36:145-67. Symp Fundam Cancer Res. 1983. PMID: 6382504 Review.
-
High dose corticosteroids and cell-cell interactions.Acta Chir Scand Suppl. 1985;526:37-47. Acta Chir Scand Suppl. 1985. PMID: 3911707 Review.
Cited by
-
Platelets and cancer metastasis: a causal relationship?Cancer Metastasis Rev. 1992 Nov;11(3-4):325-51. doi: 10.1007/BF01307186. Cancer Metastasis Rev. 1992. PMID: 1423821 Review.